Reference Source

Huaiyin Wellkong Bioeng · 66-66 · CHINA

For Huaiyin Wellkong Bioeng · 66-66 · CHINA, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is CHINA; product is Sodium Heparin; product code is 61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 3 West Beijing Road , Huaiyin, CHINA, verified against its source on 2026-09-16.

Firm
Huaiyin Wellkong Bioeng verified
Import alert
66-66
Import alert name
"APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
Country
CHINA verified
Address
3 West Beijing Road , Huaiyin, CHINA verified
Date published
09/30/2009 verified
Product code
61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf verified
Product
Sodium Heparin verified
FDA notes
11/2/2000 verified
Sourceaccessdata.fda.gov
Verified
Review by
DatasetFDA import alert red lists: firms subject to detention without physical examination

What the source says

Huaiyin Wellkong Bioeng Date Published : 09/30/2009 3 West Beijing Road , Huaiyin, CHINA 61 L - S 08 Heparin Sodium (Anti-Coagulant), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/29/2019 Desc: Sodium Heparin Notes: 11/2/2000

accessdata.fda.gov, retrieved 2026-09-15

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.

This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.